MedicaidAdministrativeLow impact
Agenda for July 24, 2026, DUR Board Meeting Now Available
Texas Medicaid·TX · Pharmacy·General
We identified it
Jul 17, 2026
Summary
The Texas Drug Utilization Review (DUR) Board has published its meeting agenda for July 24, 2026, where board members will recommend outpatient prescription drugs for Texas Medicaid, develop preferred drug list recommendations, and establish clinical prior authorization criteria. This is an informational notice about the public meeting and opportunities for stakeholder testimony; no immediate billing or coverage changes are announced.
Action Required
No immediate action required. This is a meeting announcement with no billing impact. Billing teams may monitor future DUR Board decisions that could affect Texas Medicaid pharmacy coverage and prior authorization requirements. If your practice prescribes to Texas Medicaid patients, consider reviewing the meeting outcomes once posted, particularly any new prior authorization criteria that may affect workflow.